

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.65345584 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.65345584 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.55107637 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.41092263 |
| 5 | response to peptidoglycan (GO:0032494) | 4.93926002 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.86345366 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.86345366 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.86345366 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.86345366 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.86345366 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.86345366 |
| 12 | * detection of other organism (GO:0098543) | 4.82916782 |
| 13 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.64660468 |
| 14 | * detection of external biotic stimulus (GO:0098581) | 4.59643854 |
| 15 | neutrophil activation (GO:0042119) | 4.40104417 |
| 16 | respiratory burst (GO:0045730) | 4.28897305 |
| 17 | granulocyte activation (GO:0036230) | 4.27882559 |
| 18 | superoxide anion generation (GO:0042554) | 4.24577768 |
| 19 | * detection of bacterium (GO:0016045) | 4.22771200 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.18083373 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.15299457 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.14388132 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 4.09361476 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 4.03192829 |
| 25 | * detection of biotic stimulus (GO:0009595) | 4.01342428 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.90487770 |
| 27 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.89922203 |
| 28 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.89568184 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.88000606 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.86244976 |
| 31 | regulation of RIG-I signaling pathway (GO:0039535) | 3.85978521 |
| 32 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.85189086 |
| 33 | regulation of interferon-alpha production (GO:0032647) | 3.80393914 |
| 34 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.78151459 |
| 35 | reactive oxygen species biosynthetic process (GO:1903409) | 3.75693617 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.74177623 |
| 37 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.72015131 |
| 38 | cellular response to zinc ion (GO:0071294) | 3.69064461 |
| 39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.66252387 |
| 40 | regulation of leukocyte degranulation (GO:0043300) | 3.64360985 |
| 41 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.55389572 |
| 42 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.54501655 |
| 43 | defense response to protozoan (GO:0042832) | 3.54455502 |
| 44 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.51656280 |
| 45 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.49799522 |
| 46 | neutrophil mediated immunity (GO:0002446) | 3.48597910 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.47692854 |
| 48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47281438 |
| 49 | microglial cell activation (GO:0001774) | 3.46518244 |
| 50 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.44106936 |
| 51 | response to host immune response (GO:0052572) | 3.44106936 |
| 52 | NIK/NF-kappaB signaling (GO:0038061) | 3.43403379 |
| 53 | myeloid leukocyte mediated immunity (GO:0002444) | 3.43118859 |
| 54 | negative regulation of T cell mediated immunity (GO:0002710) | 3.42438240 |
| 55 | leukocyte aggregation (GO:0070486) | 3.41599521 |
| 56 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.41477015 |
| 57 | leukocyte mediated cytotoxicity (GO:0001909) | 3.41453241 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 3.40387380 |
| 59 | positive regulation of interleukin-12 production (GO:0032735) | 3.39152695 |
| 60 | natural killer cell mediated immunity (GO:0002228) | 3.39141006 |
| 61 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.39141006 |
| 62 | positive regulation of mast cell degranulation (GO:0043306) | 3.37506377 |
| 63 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.37506377 |
| 64 | regulation of activation of Janus kinase activity (GO:0010533) | 3.36784692 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.35758825 |
| 66 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.35398434 |
| 67 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.32942825 |
| 68 | regulation of antigen processing and presentation (GO:0002577) | 3.32019284 |
| 69 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.31106380 |
| 70 | response to muramyl dipeptide (GO:0032495) | 3.30079953 |
| 71 | negative regulation of mast cell activation (GO:0033004) | 3.28636220 |
| 72 | regulation of mast cell activation (GO:0033003) | 3.27071803 |
| 73 | B cell receptor signaling pathway (GO:0050853) | 3.26391406 |
| 74 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.25940547 |
| 75 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.23865152 |
| 76 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.20673383 |
| 77 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.20445290 |
| 78 | positive regulation of mast cell activation (GO:0033005) | 3.19857476 |
| 79 | T-helper 1 type immune response (GO:0042088) | 3.19718091 |
| 80 | regulation of mast cell degranulation (GO:0043304) | 3.18996425 |
| 81 | leukocyte degranulation (GO:0043299) | 3.16805921 |
| 82 | neutrophil chemotaxis (GO:0030593) | 3.16345604 |
| 83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16325769 |
| 84 | regulation of regulated secretory pathway (GO:1903305) | 3.16054536 |
| 85 | positive regulation of heat generation (GO:0031652) | 3.15256142 |
| 86 | negative regulation of interleukin-17 production (GO:0032700) | 3.14203158 |
| 87 | positive regulation of interferon-beta production (GO:0032728) | 3.13504094 |
| 88 | regulation of tolerance induction (GO:0002643) | 3.13248580 |
| 89 | positive regulation of B cell differentiation (GO:0045579) | 3.12653242 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.12114175 |
| 91 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.11692694 |
| 92 | response to interleukin-15 (GO:0070672) | 3.10815314 |
| 93 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.10333972 |
| 94 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.10276129 |
| 95 | macrophage activation (GO:0042116) | 3.09393368 |
| 96 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.08266687 |
| 97 | neutrophil migration (GO:1990266) | 3.08220346 |
| 98 | response to protozoan (GO:0001562) | 3.07078497 |
| 99 | dendritic cell chemotaxis (GO:0002407) | 3.06850072 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.04082537 |
| 101 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04040751 |
| 102 | positive regulation of leukocyte degranulation (GO:0043302) | 3.03152603 |
| 103 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.02869405 |
| 104 | cellular response to type I interferon (GO:0071357) | 3.02310654 |
| 105 | type I interferon signaling pathway (GO:0060337) | 3.02310654 |
| 106 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.01749221 |
| 107 | dendritic cell migration (GO:0036336) | 3.00156652 |
| 108 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99571799 |
| 109 | response to host (GO:0075136) | 2.99571799 |
| 110 | response to host defenses (GO:0052200) | 2.99571799 |
| 111 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.99472226 |
| 112 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.99080631 |
| 113 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.98474794 |
| 114 | regulation of chemokine biosynthetic process (GO:0045073) | 2.98178701 |
| 115 | response to type I interferon (GO:0034340) | 2.97928293 |
| 116 | mature B cell differentiation (GO:0002335) | 2.97545765 |
| 117 | detection of molecule of bacterial origin (GO:0032490) | 2.96019880 |
| 118 | B cell mediated immunity (GO:0019724) | 2.95844981 |
| 119 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.95343988 |
| 120 | germinal center formation (GO:0002467) | 2.94531734 |
| 121 | regulation of T cell tolerance induction (GO:0002664) | 2.93866755 |
| 122 | myeloid dendritic cell activation (GO:0001773) | 2.93621413 |
| 123 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.93535106 |
| 124 | cellular extravasation (GO:0045123) | 2.93421147 |
| 125 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.93114320 |
| 126 | positive regulation of type 2 immune response (GO:0002830) | 2.92765542 |
| 127 | cellular response to interferon-beta (GO:0035458) | 2.91691179 |
| 128 | regulation of macrophage cytokine production (GO:0010935) | 2.91249394 |
| 129 | negative regulation of interleukin-12 production (GO:0032695) | 2.90639486 |
| 130 | regulation of interleukin-12 production (GO:0032655) | 2.90233793 |
| 131 | leukotriene metabolic process (GO:0006691) | 2.90193007 |
| 132 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90048959 |
| 133 | regulation of fever generation (GO:0031620) | 2.89144474 |
| 134 | positive regulation of lymphocyte migration (GO:2000403) | 2.88993512 |
| 135 | regulation of B cell differentiation (GO:0045577) | 2.88722410 |
| 136 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.88203653 |
| 137 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.87094792 |
| 138 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.86622525 |
| 139 | myeloid leukocyte activation (GO:0002274) | 2.85762846 |
| 140 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.85291366 |
| 141 | positive regulation of regulated secretory pathway (GO:1903307) | 2.82875810 |
| 142 | negative regulation of interleukin-6 production (GO:0032715) | 2.82555760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.90015262 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.65367798 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.31280330 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.38669548 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.34917242 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.96438574 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.89518201 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.65702395 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.43221011 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.26431339 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.08659714 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92976231 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.83610763 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.77502461 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.76555000 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.65003123 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.48588138 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.42276244 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.07029164 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.94088556 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92447238 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87026036 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.86950115 |
| 24 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.82648440 |
| 25 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.79620587 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78395929 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.78216275 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74689670 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.73775173 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67621801 |
| 31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.67020505 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66060629 |
| 33 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.65670657 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65402808 |
| 35 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59740000 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59469452 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.57752677 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56169584 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55848095 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54564437 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53413987 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51305911 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49928082 |
| 44 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49775186 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47914174 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47344590 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.45212168 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43206155 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40674954 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.35589030 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33266316 |
| 52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31833920 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.31572114 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30064853 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29960119 |
| 56 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29646032 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.26939675 |
| 58 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25075576 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24610207 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24154444 |
| 61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23872537 |
| 62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.22579271 |
| 63 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22533587 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22122656 |
| 65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21578342 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19388152 |
| 67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19314320 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17676895 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17637167 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17023396 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16421032 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13967672 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12788465 |
| 74 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11560283 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11502083 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08950291 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08441529 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06728630 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06465492 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05982486 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05711434 |
| 82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04320401 |
| 83 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.02372867 |
| 84 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02012011 |
| 85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01312147 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00928901 |
| 87 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00503574 |
| 88 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.98775412 |
| 89 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97460763 |
| 90 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96806241 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96424573 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 0.96343131 |
| 93 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94293700 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93779136 |
| 95 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.93264725 |
| 96 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.93241338 |
| 97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92805478 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92588643 |
| 99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92477278 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92073173 |
| 101 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.90934234 |
| 102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89473348 |
| 103 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89033846 |
| 104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87408113 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85730249 |
| 106 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.85460356 |
| 107 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84517094 |
| 108 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84075542 |
| 109 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84055856 |
| 110 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.83973654 |
| 111 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83662752 |
| 112 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.83349222 |
| 113 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.83337382 |
| 114 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.82964520 |
| 115 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.82175820 |
| 116 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82151613 |
| 117 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81995320 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81921117 |
| 119 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.80846551 |
| 120 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.80148147 |
| 121 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.78371519 |
| 122 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.77954679 |
| 123 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77732243 |
| 124 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77726444 |
| 125 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.77593817 |
| 126 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.77141386 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76864657 |
| 128 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.76779065 |
| 129 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.76319581 |
| 130 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.76277406 |
| 131 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.76025997 |
| 132 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.75681323 |
| 133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75670073 |
| 134 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.74971453 |
| 135 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.74301144 |
| 136 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.73645148 |
| 137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73294395 |
| 138 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.73038100 |
| 139 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.71837138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.24811970 |
| 2 | MP0009785_altered_susceptibility_to | 3.94671531 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.93163701 |
| 4 | MP0003436_decreased_susceptibility_to | 3.44046297 |
| 5 | * MP0002419_abnormal_innate_immunity | 3.33359377 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.32463389 |
| 7 | * MP0005025_abnormal_response_to | 3.10241427 |
| 8 | MP0001790_abnormal_immune_system | 3.04850962 |
| 9 | MP0005387_immune_system_phenotype | 3.04850962 |
| 10 | * MP0002452_abnormal_antigen_presenting | 2.95404067 |
| 11 | MP0001800_abnormal_humoral_immune | 2.92761225 |
| 12 | MP0005671_abnormal_response_to | 2.82173616 |
| 13 | MP0006082_CNS_inflammation | 2.75993868 |
| 14 | MP0000685_abnormal_immune_system | 2.72954996 |
| 15 | * MP0002723_abnormal_immune_serum | 2.68816186 |
| 16 | MP0003724_increased_susceptibility_to | 2.57066839 |
| 17 | * MP0001819_abnormal_immune_cell | 2.49098681 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.46220802 |
| 19 | MP0003183_abnormal_peptide_metabolism | 2.29129363 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.23690781 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.08133012 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.03991087 |
| 23 | MP0000569_abnormal_digit_pigmentation | 2.03007360 |
| 24 | MP0005310_abnormal_salivary_gland | 2.01600843 |
| 25 | MP0003303_peritoneal_inflammation | 2.00747883 |
| 26 | MP0001845_abnormal_inflammatory_respons | 1.99540292 |
| 27 | MP0002405_respiratory_system_inflammati | 1.92586743 |
| 28 | MP0009764_decreased_sensitivity_to | 1.85622108 |
| 29 | MP0002006_tumorigenesis | 1.85594970 |
| 30 | MP0004947_skin_inflammation | 1.85381278 |
| 31 | MP0004510_myositis | 1.83094056 |
| 32 | MP0000716_abnormal_immune_system | 1.79335716 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.73123954 |
| 34 | MP0001853_heart_inflammation | 1.69718551 |
| 35 | MP0004883_abnormal_blood_vessel | 1.67574395 |
| 36 | MP0002398_abnormal_bone_marrow | 1.66794766 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.62088094 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.56863028 |
| 39 | MP0002132_abnormal_respiratory_system | 1.56003805 |
| 40 | MP0008469_abnormal_protein_level | 1.54369362 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.48294377 |
| 42 | MP0005451_abnormal_body_composition | 1.46768062 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.44949643 |
| 44 | MP0000604_amyloidosis | 1.43949538 |
| 45 | MP0002429_abnormal_blood_cell | 1.43372618 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.40633329 |
| 47 | MP0002277_abnormal_respiratory_mucosa | 1.38724124 |
| 48 | MP0003448_altered_tumor_morphology | 1.37566672 |
| 49 | MP0001873_stomach_inflammation | 1.36005488 |
| 50 | MP0000858_altered_metastatic_potential | 1.35528998 |
| 51 | MP0009840_abnormal_foam_cell | 1.27775696 |
| 52 | MP0000490_abnormal_crypts_of | 1.27728586 |
| 53 | MP0002722_abnormal_immune_system | 1.24897801 |
| 54 | MP0003075_altered_response_to | 1.24149331 |
| 55 | MP0000343_altered_response_to | 1.22939666 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.21466008 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.19970101 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.19254113 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.16435089 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.16012524 |
| 61 | MP0004381_abnormal_hair_follicle | 1.13574494 |
| 62 | MP0003866_abnormal_defecation | 1.13439525 |
| 63 | MP0005166_decreased_susceptibility_to | 1.13133677 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 1.10943802 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.07268943 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.07268943 |
| 67 | MP0009278_abnormal_bone_marrow | 1.05729120 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.00612002 |
| 69 | MP0002396_abnormal_hematopoietic_system | 0.98748132 |
| 70 | MP0008057_abnormal_DNA_replication | 0.98041524 |
| 71 | MP0008260_abnormal_autophagy | 0.97874073 |
| 72 | MP0003828_pulmonary_edema | 0.97104727 |
| 73 | MP0003186_abnormal_redox_activity | 0.94023503 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 0.93924108 |
| 75 | MP0001663_abnormal_digestive_system | 0.91199103 |
| 76 | MP0002933_joint_inflammation | 0.89249515 |
| 77 | MP0009763_increased_sensitivity_to | 0.86089724 |
| 78 | MP0008004_abnormal_stomach_pH | 0.85968433 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.84846229 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 0.82092552 |
| 81 | MP0002254_reproductive_system_inflammat | 0.81861223 |
| 82 | MP0003690_abnormal_glial_cell | 0.81543004 |
| 83 | MP0010307_abnormal_tumor_latency | 0.79362908 |
| 84 | MP0001666_abnormal_nutrient_absorption | 0.79287117 |
| 85 | MP0005390_skeleton_phenotype | 0.76998384 |
| 86 | MP0005075_abnormal_melanosome_morpholog | 0.74845315 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74550049 |
| 88 | MP0000371_diluted_coat_color | 0.74301457 |
| 89 | MP0003329_amyloid_beta_deposits | 0.74228571 |
| 90 | MP0009697_abnormal_copulation | 0.73427354 |
| 91 | MP0000249_abnormal_blood_vessel | 0.72566778 |
| 92 | MP0004130_abnormal_muscle_cell | 0.72134757 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.71620424 |
| 94 | MP0003300_gastrointestinal_ulcer | 0.71411976 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 0.70548921 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.70261447 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.70011233 |
| 98 | MP0008874_decreased_physiological_sensi | 0.65773469 |
| 99 | MP0002332_abnormal_exercise_endurance | 0.65693100 |
| 100 | MP0010352_gastrointestinal_tract_polyps | 0.65279469 |
| 101 | MP0005164_abnormal_response_to | 0.65264629 |
| 102 | MP0000920_abnormal_myelination | 0.64921892 |
| 103 | MP0004808_abnormal_hematopoietic_stem | 0.61805569 |
| 104 | MP0003045_fibrosis | 0.60740214 |
| 105 | MP0000470_abnormal_stomach_morphology | 0.59369195 |
| 106 | MP0002163_abnormal_gland_morphology | 0.55071145 |
| 107 | MP0002133_abnormal_respiratory_system | 0.54697229 |
| 108 | MP0005388_respiratory_system_phenotype | 0.54697229 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.54696509 |
| 110 | MP0001958_emphysema | 0.54212778 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.54183250 |
| 112 | MP0003795_abnormal_bone_structure | 0.53487633 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.53175291 |
| 114 | MP0004484_altered_response_of | 0.52499863 |
| 115 | MP0006054_spinal_hemorrhage | 0.51300150 |
| 116 | MP0005171_absent_coat_pigmentation | 0.50369248 |
| 117 | MP0003091_abnormal_cell_migration | 0.48931685 |
| 118 | MP0000703_abnormal_thymus_morphology | 0.48099018 |
| 119 | MP0001851_eye_inflammation | 0.47921093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.37373209 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.66568201 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.65123081 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.35294418 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.85761076 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.70159533 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.52554406 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.35346156 |
| 9 | Gingivitis (HP:0000230) | 4.26921765 |
| 10 | Recurrent skin infections (HP:0001581) | 4.15123773 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.11595040 |
| 12 | Obstructive lung disease (HP:0006536) | 4.09805129 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.09805129 |
| 14 | Stomatitis (HP:0010280) | 3.99309149 |
| 15 | Vasculitis (HP:0002633) | 3.87399824 |
| 16 | Myositis (HP:0100614) | 3.82564683 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.82333676 |
| 18 | Optic neuritis (HP:0100653) | 3.82333676 |
| 19 | Recurrent viral infections (HP:0004429) | 3.71323536 |
| 20 | Prostate neoplasm (HP:0100787) | 3.69273946 |
| 21 | Pustule (HP:0200039) | 3.60329822 |
| 22 | Orchitis (HP:0100796) | 3.55142994 |
| 23 | Cellulitis (HP:0100658) | 3.34898367 |
| 24 | Periodontitis (HP:0000704) | 3.28699868 |
| 25 | Meningitis (HP:0001287) | 3.28692136 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.26364267 |
| 27 | Prolonged bleeding time (HP:0003010) | 3.24430775 |
| 28 | Recurrent pneumonia (HP:0006532) | 3.20539972 |
| 29 | Chronic diarrhea (HP:0002028) | 3.08007073 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.07219475 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.07219475 |
| 32 | T lymphocytopenia (HP:0005403) | 3.06346264 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 2.96985517 |
| 34 | Osteomyelitis (HP:0002754) | 2.92161691 |
| 35 | Amyloidosis (HP:0011034) | 2.89805915 |
| 36 | Agammaglobulinemia (HP:0004432) | 2.89619758 |
| 37 | Chest pain (HP:0100749) | 2.86784194 |
| 38 | Epistaxis (HP:0000421) | 2.84622478 |
| 39 | Leukocytosis (HP:0001974) | 2.79694390 |
| 40 | Pulmonary infiltrates (HP:0002113) | 2.77111516 |
| 41 | Basal ganglia calcification (HP:0002135) | 2.76972096 |
| 42 | Thick nail (HP:0001805) | 2.76072338 |
| 43 | Peritonitis (HP:0002586) | 2.75067587 |
| 44 | Episodic fever (HP:0001954) | 2.73670499 |
| 45 | Abnormality of the prostate (HP:0008775) | 2.69238098 |
| 46 | Thyroiditis (HP:0100646) | 2.68684609 |
| 47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.68653626 |
| 48 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.68551593 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.67047820 |
| 50 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.67018229 |
| 51 | Recurrent lower respiratory tract infections (HP:0002783) | 2.66113478 |
| 52 | Gastrointestinal stroma tumor (HP:0100723) | 2.65674751 |
| 53 | Loss of speech (HP:0002371) | 2.65597656 |
| 54 | Anorexia (HP:0002039) | 2.64211969 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.62796694 |
| 56 | Colitis (HP:0002583) | 2.61780108 |
| 57 | Petechiae (HP:0000967) | 2.59750754 |
| 58 | Eosinophilia (HP:0001880) | 2.59013712 |
| 59 | Increased IgM level (HP:0003496) | 2.56286297 |
| 60 | Urticaria (HP:0001025) | 2.52393268 |
| 61 | Chromsome breakage (HP:0040012) | 2.51861656 |
| 62 | Pulmonary embolism (HP:0002204) | 2.51256720 |
| 63 | Chronic otitis media (HP:0000389) | 2.49700045 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.47996043 |
| 65 | Increased cerebral lipofuscin (HP:0011813) | 2.43871397 |
| 66 | Sepsis (HP:0100806) | 2.43121039 |
| 67 | Recurrent sinusitis (HP:0011108) | 2.42484016 |
| 68 | IgM deficiency (HP:0002850) | 2.41782879 |
| 69 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.41232169 |
| 70 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.41232169 |
| 71 | Abnormality of glycolipid metabolism (HP:0010969) | 2.41232169 |
| 72 | Premature loss of primary teeth (HP:0006323) | 2.36051053 |
| 73 | Gastrointestinal infarctions (HP:0005244) | 2.35481829 |
| 74 | Hypergammaglobulinemia (HP:0010702) | 2.34133374 |
| 75 | Hemoptysis (HP:0002105) | 2.33727999 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.31999314 |
| 77 | Hypochromic anemia (HP:0001931) | 2.31135642 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.29843627 |
| 79 | Abnormality of T cells (HP:0002843) | 2.29789373 |
| 80 | Axonal loss (HP:0003447) | 2.26678769 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.25807946 |
| 82 | Abnormality of eosinophils (HP:0001879) | 2.24968276 |
| 83 | Gastrointestinal inflammation (HP:0004386) | 2.24856296 |
| 84 | Gangrene (HP:0100758) | 2.22863430 |
| 85 | Granulocytopenia (HP:0001913) | 2.22235409 |
| 86 | Combined immunodeficiency (HP:0005387) | 2.19621160 |
| 87 | Keratoconjunctivitis (HP:0001096) | 2.19343867 |
| 88 | Autoimmune hemolytic anemia (HP:0001890) | 2.18293756 |
| 89 | Gingival bleeding (HP:0000225) | 2.16898891 |
| 90 | Lymphopenia (HP:0001888) | 2.16705016 |
| 91 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.16698047 |
| 92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.14886206 |
| 93 | IgA deficiency (HP:0002720) | 2.14447260 |
| 94 | Abnormality of the peritoneum (HP:0002585) | 2.13011756 |
| 95 | Restrictive lung disease (HP:0002091) | 2.12171091 |
| 96 | Disinhibition (HP:0000734) | 2.11855931 |
| 97 | Arterial thrombosis (HP:0004420) | 2.11838596 |
| 98 | Abnormal platelet volume (HP:0011876) | 2.10841065 |
| 99 | Abnormality of the pleura (HP:0002103) | 2.09583558 |
| 100 | Increased serum ferritin (HP:0003281) | 2.08523698 |
| 101 | Myocardial infarction (HP:0001658) | 2.07256276 |
| 102 | Encephalitis (HP:0002383) | 2.07027477 |
| 103 | Abnormality of the endocardium (HP:0004306) | 2.07022065 |
| 104 | Vertigo (HP:0002321) | 2.05306923 |
| 105 | Severe combined immunodeficiency (HP:0004430) | 2.04356298 |
| 106 | Polyneuropathy (HP:0001271) | 2.04088410 |
| 107 | Glomerulopathy (HP:0100820) | 2.03926839 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 2.03294034 |
| 109 | Microcytic anemia (HP:0001935) | 2.03220565 |
| 110 | Panhypogammaglobulinemia (HP:0003139) | 2.01285619 |
| 111 | Arthralgia (HP:0002829) | 1.99077947 |
| 112 | Poor head control (HP:0002421) | 1.99040482 |
| 113 | Leukopenia (HP:0001882) | 1.97330290 |
| 114 | Abnormality of T cell number (HP:0011839) | 1.96449867 |
| 115 | Agnosia (HP:0010524) | 1.95805779 |
| 116 | Abnormality of B cell number (HP:0010975) | 1.93702278 |
| 117 | B lymphocytopenia (HP:0010976) | 1.93702278 |
| 118 | Cheilitis (HP:0100825) | 1.92989720 |
| 119 | Skin ulcer (HP:0200042) | 1.92736279 |
| 120 | Increased IgE level (HP:0003212) | 1.90167845 |
| 121 | Thrombocytosis (HP:0001894) | 1.87567329 |
| 122 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.87377645 |
| 123 | Emphysema (HP:0002097) | 1.87197147 |
| 124 | Slow saccadic eye movements (HP:0000514) | 1.86292559 |
| 125 | Spontaneous hematomas (HP:0007420) | 1.85805610 |
| 126 | Recurrent bronchitis (HP:0002837) | 1.85174627 |
| 127 | Keratitis (HP:0000491) | 1.83013488 |
| 128 | Hematochezia (HP:0002573) | 1.81651877 |
| 129 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.81650109 |
| 130 | Clubbing of toes (HP:0100760) | 1.81533824 |
| 131 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81405310 |
| 132 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81405310 |
| 133 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81405310 |
| 134 | Abnormality of male internal genitalia (HP:0000022) | 1.81330778 |
| 135 | Purpura (HP:0000979) | 1.80629325 |
| 136 | Acne (HP:0001061) | 1.80264497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.11137110 |
| 2 | BLK | 4.25598315 |
| 3 | RIPK4 | 3.90360407 |
| 4 | IRAK4 | 3.74730927 |
| 5 | IRAK3 | 3.50372113 |
| 6 | MAP4K1 | 3.31318056 |
| 7 | MAP2K3 | 3.18219929 |
| 8 | TBK1 | 2.76577082 |
| 9 | TXK | 2.64232288 |
| 10 | MST4 | 2.52797986 |
| 11 | IKBKB | 2.37301374 |
| 12 | IKBKE | 2.28497277 |
| 13 | TYK2 | 2.25309590 |
| 14 | MAP3K13 | 2.15482985 |
| 15 | JAK3 | 2.03937961 |
| 16 | PBK | 1.84590925 |
| 17 | BMPR2 | 1.82670915 |
| 18 | MAP3K3 | 1.81158728 |
| 19 | TNK2 | 1.76527349 |
| 20 | KIT | 1.69905940 |
| 21 | JAK1 | 1.65044612 |
| 22 | SYK | 1.59420576 |
| 23 | TAOK3 | 1.55412793 |
| 24 | CHUK | 1.55150493 |
| 25 | TAOK1 | 1.54652877 |
| 26 | CSF1R | 1.53784541 |
| 27 | NUAK1 | 1.50212563 |
| 28 | NEK9 | 1.44133510 |
| 29 | BTK | 1.42560146 |
| 30 | MAP3K11 | 1.39490640 |
| 31 | MST1R | 1.37916703 |
| 32 | KSR2 | 1.36303831 |
| 33 | TEC | 1.35834960 |
| 34 | LYN | 1.31705589 |
| 35 | MAP3K1 | 1.31374185 |
| 36 | EIF2AK2 | 1.29569017 |
| 37 | STK10 | 1.27885779 |
| 38 | YES1 | 1.25090057 |
| 39 | MAP3K6 | 1.24942277 |
| 40 | PIM1 | 1.22079751 |
| 41 | PIM2 | 1.20906073 |
| 42 | FRK | 1.18218213 |
| 43 | HCK | 1.16695789 |
| 44 | MAP3K2 | 1.15118102 |
| 45 | CSK | 1.12461164 |
| 46 | PIK3CG | 1.05496597 |
| 47 | BMPR1B | 1.04115408 |
| 48 | TRPM7 | 1.03508934 |
| 49 | IRAK2 | 1.01203874 |
| 50 | FGR | 0.99013719 |
| 51 | LCK | 0.98288568 |
| 52 | NME2 | 0.96423154 |
| 53 | ZAP70 | 0.95435205 |
| 54 | SIK3 | 0.94557996 |
| 55 | MATK | 0.91798685 |
| 56 | MARK2 | 0.90059439 |
| 57 | GRK1 | 0.89994335 |
| 58 | STK4 | 0.88019192 |
| 59 | CAMKK2 | 0.83420699 |
| 60 | MAP2K4 | 0.83193212 |
| 61 | MARK3 | 0.81699076 |
| 62 | RPS6KA4 | 0.80614571 |
| 63 | CLK1 | 0.79924283 |
| 64 | MAP3K5 | 0.77527165 |
| 65 | BMX | 0.75740272 |
| 66 | TAOK2 | 0.75606074 |
| 67 | STK3 | 0.74341693 |
| 68 | NLK | 0.74176091 |
| 69 | GRK6 | 0.71621310 |
| 70 | ERN1 | 0.71462928 |
| 71 | PTK2B | 0.68756326 |
| 72 | * PRKCD | 0.67908085 |
| 73 | JAK2 | 0.67095828 |
| 74 | KSR1 | 0.64793515 |
| 75 | EIF2AK3 | 0.64258569 |
| 76 | EPHA3 | 0.64074874 |
| 77 | PTK6 | 0.63900823 |
| 78 | EPHB1 | 0.63709563 |
| 79 | ABL1 | 0.62361953 |
| 80 | SGK3 | 0.62277302 |
| 81 | ZAK | 0.62104072 |
| 82 | MAPK12 | 0.60769984 |
| 83 | PRKCQ | 0.60739718 |
| 84 | ACVR1B | 0.60297409 |
| 85 | FES | 0.59051393 |
| 86 | GRK7 | 0.58729605 |
| 87 | CDC42BPA | 0.58609000 |
| 88 | ADRBK2 | 0.58109596 |
| 89 | ABL2 | 0.57606274 |
| 90 | RAF1 | 0.57220654 |
| 91 | ERBB4 | 0.56840032 |
| 92 | PRKD2 | 0.56328140 |
| 93 | ERBB3 | 0.55748288 |
| 94 | CDK19 | 0.53559503 |
| 95 | RET | 0.53319850 |
| 96 | MAP2K6 | 0.51519978 |
| 97 | ITK | 0.51490403 |
| 98 | SIK2 | 0.51275232 |
| 99 | TESK2 | 0.51201036 |
| 100 | PRPF4B | 0.50299290 |
| 101 | STK11 | 0.48742234 |
| 102 | MAPKAPK2 | 0.47620500 |
| 103 | EGFR | 0.47276668 |
| 104 | FGFR4 | 0.45320979 |
| 105 | PLK4 | 0.45230343 |
| 106 | MAPK7 | 0.45103463 |
| 107 | MAP3K10 | 0.44394762 |
| 108 | DAPK2 | 0.43268984 |
| 109 | IRAK1 | 0.42502887 |
| 110 | FGFR3 | 0.40895694 |
| 111 | NEK6 | 0.39386751 |
| 112 | WNK1 | 0.39213938 |
| 113 | CDK12 | 0.38303242 |
| 114 | MAP3K7 | 0.38075204 |
| 115 | AKT3 | 0.37931144 |
| 116 | PDK1 | 0.37155728 |
| 117 | DYRK1B | 0.35130447 |
| 118 | MAP3K12 | 0.34855542 |
| 119 | PRKG2 | 0.34332082 |
| 120 | CAMKK1 | 0.33862989 |
| 121 | CAMK1D | 0.31343450 |
| 122 | PKN1 | 0.30911810 |
| 123 | TGFBR2 | 0.30802881 |
| 124 | BRD4 | 0.28201178 |
| 125 | HIPK2 | 0.27746053 |
| 126 | PDPK1 | 0.26748565 |
| 127 | CAMK4 | 0.26632309 |
| 128 | CDK6 | 0.26373757 |
| 129 | RPS6KA6 | 0.25460508 |
| 130 | STK24 | 0.24015486 |
| 131 | FYN | 0.22845009 |
| 132 | ARAF | 0.22303600 |
| 133 | CDK4 | 0.21116007 |
| 134 | ATR | 0.20513556 |
| 135 | SGK2 | 0.19086136 |
| 136 | MOS | 0.16271418 |
| 137 | VRK1 | 0.16147109 |
| 138 | LRRK2 | 0.14811897 |
| 139 | RPS6KL1 | 0.14802861 |
| 140 | RPS6KC1 | 0.14802861 |
| 141 | TNIK | 0.14519463 |
| 142 | IGF1R | 0.14164373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.24646566 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.22699061 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.93650102 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.74160698 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.70356087 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.64926761 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.61630022 |
| 8 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.46136961 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35615105 |
| 10 | * Legionellosis_Homo sapiens_hsa05134 | 2.32248164 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.19010787 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.17441683 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.13339981 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.10734604 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 2.06548507 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.06163384 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.05425572 |
| 18 | Measles_Homo sapiens_hsa05162 | 2.05019283 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.96012759 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.95767558 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94075987 |
| 22 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.81947095 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.81580565 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.81287924 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.78476837 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.77140992 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.75825966 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69798429 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.55478097 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52601115 |
| 31 | * Salmonella infection_Homo sapiens_hsa05132 | 1.49806931 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.45834919 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.39029924 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.38915898 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30995956 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28580386 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.27461978 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24454540 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21769516 |
| 40 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.19828523 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16478658 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16223911 |
| 43 | Mineral absorption_Homo sapiens_hsa04978 | 1.14796320 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09617330 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07033393 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06404705 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06245594 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05855916 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00856708 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98982637 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.93686309 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92482426 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.90737644 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 0.89357810 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80396828 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77595202 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77313666 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74233886 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72081298 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70673979 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.69396553 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68599544 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67927574 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67881809 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67680071 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67054706 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65656098 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.65319097 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65122050 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64892125 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61840552 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58897753 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58286807 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57048875 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57023714 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55967498 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55849755 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55084517 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53517627 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52537614 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50944935 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48855716 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46297699 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46198704 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45423192 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43770926 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43038927 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42890091 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42086411 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40063545 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40048233 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.39429311 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38744310 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.38254943 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37512935 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.36538103 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34285934 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33799435 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33742900 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33728479 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33063836 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32788842 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31985796 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31869876 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.31476888 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31321316 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31078440 |
| 108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30936512 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29770876 |
| 110 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.29505387 |
| 111 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.26131556 |
| 112 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.25639740 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22333648 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21373888 |
| 115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20782531 |
| 116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.20601615 |
| 117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.19328403 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19112845 |
| 119 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.18858427 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.18638859 |
| 121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.18580057 |
| 122 | Homologous recombination_Homo sapiens_hsa03440 | 0.18207119 |
| 123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.16847645 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.15132075 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14987891 |

